Zentek Beheer

Beheer criteriumcontroles 0/4

De CEO Zentek is Greg Fenton, benoemd in Dec2020, heeft een ambtstermijn van 3.92 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 542.50K, bestaande uit 59.9% salaris en 40.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 2.98% van de aandelen van het bedrijf, ter waarde CA$ 3.45M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.9 jaar en 2.9 jaar.

Belangrijke informatie

Greg Fenton

Algemeen directeur

CA$542.5k

Totale compensatie

Percentage CEO-salaris	59.9%
Dienstverband CEO	3.9yrs
Eigendom CEO	3.0%
Management gemiddelde ambtstermijn	1.9yrs
Gemiddelde ambtstermijn bestuur	2.9yrs

Recente managementupdates

Recent updates

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Jul 09

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

Aug 31

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

Mar 11

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Nov 26

Analyse CEO-vergoeding

Hoe is Greg Fenton's beloning veranderd ten opzichte van Zentek's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-CA$11m
Mar 31 2024	CA$543k	CA$325k	-CA$12m
Dec 31 2023	n/a	n/a	-CA$12m
Sep 30 2023	n/a	n/a	-CA$13m
Jun 30 2023	n/a	n/a	-CA$13m
Mar 31 2023	CA$325k	CA$325k	-CA$14m
Dec 31 2022	n/a	n/a	-CA$36m
Sep 30 2022	n/a	n/a	-CA$35m
Jun 30 2022	n/a	n/a	-CA$35m
Mar 31 2022	CA$1m	CA$200k	-CA$32m
Dec 31 2021	n/a	n/a	-CA$8m
Sep 30 2021	n/a	n/a	-CA$8m
Jun 30 2021	n/a	n/a	-CA$5m
Mar 31 2021	CA$906k	CA$138k	-CA$4m
Dec 31 2020	n/a	n/a	-CA$4m
Sep 30 2020	n/a	n/a	-CA$2m
Jun 30 2020	n/a	n/a	-CA$2m
Mar 31 2020	CA$51k	n/a	-CA$2m
Dec 31 2019	n/a	n/a	-CA$2m
Sep 30 2019	n/a	n/a	-CA$2m
Jun 30 2019	n/a	n/a	-CA$3m
Mar 31 2019	CA$126k	n/a	-CA$2m

Compensatie versus markt: De totale vergoeding ($USD 389.21K ) Greg } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 172.18K ).

Compensatie versus inkomsten: De vergoeding van Greg is gestegen terwijl het bedrijf verliesgevend is.

CEO

Greg Fenton

3.9yrs

Tenure

CA$542,500

Compensatie

Mr. Gregory Fenton, CFA, also known as Greg, has been Chief Executive Officer of Zentek Ltd. (formerly known as ZEN Graphene Solutions Ltd.) since December 8, 2020 and served as its Chief Strategy Officer...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Gregory Fenton	CEO & Director	3.9yrs	CA$542.50k	2.98% CA$ 3.4m
Wendy Ford	Chief Financial Officer	2.5yrs	CA$348.75k	0.0096% CA$ 11.1k
Colin van Kuur	Chief Science Officer	1.3yrs	CA$185.00k	0.26% CA$ 299.0k
Ryan Shacklock	Senior Vice President of Strategy & Business Development	1.3yrs	CA$376.50k	0.17% CA$ 197.8k

1.9yrs

Gemiddelde duur

Ervaren management: Het managementteam van ZEN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.9 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Gregory Fenton	CEO & Director	6.3yrs	CA$542.50k	2.98% CA$ 3.4m
Ilse Treurnicht	Independent Director	2.3yrs	CA$85.00k	0.0014% CA$ 1.7k
Ravi Kaza	Member of the Advisory Board	2.7yrs	geen gegevens	geen gegevens
John Snisarenko	Independent Director	1.1yrs	CA$304.38k	0.019% CA$ 22.2k
Kenneth Reed	Member of Advisory Board	3.4yrs	geen gegevens	geen gegevens
Brian Bosse	Member of the Advisory Board	less than a year	CA$36.25k	0% CA$ 0
Eric Wallman	Independent Non-Executive Chairman of the Board	6.5yrs	CA$108.13k	0.40% CA$ 461.5k
Yingfu Li	Member of Advisory Board	3.1yrs	geen gegevens	geen gegevens
Joseph Korkis	Member of Advisory Board	3.1yrs	geen gegevens	geen gegevens
Lisa Sim	Independent Director	1.4yrs	CA$415.63k	geen gegevens

2.9yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ZEN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.9 jaar), wat duidt op een nieuw bestuur.

Zentek Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Director exercised options to buy CA$376k worth of stock.

CEO & Director exercised options to buy CA$308k worth of stock.

Zentek Ltd. Announces Board and Management Changes

Zentek Ltd. Announces Board Changes

Chief Science Officer exercised options to buy CA$61k worth of stock.

Zentek Ltd. Elects John Snisarenko as Director

Recent updates

New minor risk - Share price stability

Zentek Ltd. Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters

Zentek Ltd. Provides Market Update on ZenGUARD Antimicrobial Surgical Masks

New minor risk - Shareholder dilution

Zentek Ltd. announced that it has received CAD 3.06995 million in funding

Director exercised options to buy CA$376k worth of stock.

Zentek Ltd. announced that it expects to receive CAD 3 million in funding

Full year 2024 earnings released: CA$0.12 loss per share (vs CA$0.14 loss in FY 2023)

CEO & Director exercised options to buy CA$308k worth of stock.

Zentek Ltd. Announces Board and Management Changes

Zentek Ltd. Provides ZenGUARD Business Update

New major risk - Financial position

Zentek Ltd.'s Subsidiary Triera Biosciences Ltd. Completes Testing of Its C19HBA Aptamer as Potential Therapeutic

Zentek Ltd. Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

Zentek Ltd. Announces Board Changes

Zentek Ltd. Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

Zentek Ltd. announced a financing transaction

Chief Science Officer exercised options to buy CA$61k worth of stock.

Zentek Ltd. Completes Return on Investment Analysis for Canadian Healthcare System

Zentek Ltd. Elects John Snisarenko as Director

Zentek Ltd Announces the Successful Results of A Recent Study Conducted by ParticleOne

Zentek Ltd. Announces the Results of Study Comparing the Viral Filtration Efficiency of Its Zenguard-Enhanced MERV 9 Filters with an Uncoated MERV 9 Filter

CEO & Director exercised options to buy CA$275k worth of stock.

First quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.051 loss in 1Q 2023)

Zentek Ltd., Annual General Meeting, Oct 05, 2023

Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential

Zentek Ltd. Announces Updates to Senior Management Team

COO & Director exercised options to buy CA$634k worth of stock.

Zentek Receives a Deficiency Letter from Nasdaq Stock Market LLC

Full year 2023 earnings released: CA$0.14 loss per share (vs CA$0.13 loss in FY 2022)

Zentek Ltd. Appoints Lisa Sim to the Board of Directors

Albany Graphite Corp. acquired Albany Graphite Project from Zentek Ltd. for approximately CAD 136 million.

Zentek Ltd. Introduces A Novel Corrosion Protection Technology: ZenARMOR

Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating

Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating

Zentek Ltd. Announces Appointment of Mitch Swergold as Director of Investor Relations

Zentek Ltd Announces Successful Phase 2 Results of HVAC Testing

Less than half of directors are independent

Zentek Ltd. Provides Update on Battery Technology Development

Zentek Provides Update on Icephobic Coating Technology

Zentek Ltd. Provides Update on HVAC Testing

Zentek Ltd., Annual General Meeting, Sep 29, 2022

Zentek Files Provisional Patent on the Use of ZenGUARD as an Anti-Inflammatory Agent

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Zentek Ltd. Appoints Ilse Treurnicht to Its Board of Directors

Zentek Ltd. Provides Update on ZenGUARDTM Patent Status

Zentek Ltd. Announces Chief Financial Officer Changes

Less than half of directors are independent

Zentek Ltd. Announces Start of Phase Two Testing of Zenguardtm -Coated Filters

Zentek Ltd. Announces Filing of Provisional Patent for Fire-Retardant Additive

Zentek Ltd. Appoints Ravi Kaza to Its Advisory Board

Zentek Ltd. Announces Development of Graphene-Wrapped Silicon Anodes

Zentek Ltd. announced that it has received CAD 10.009022 million in funding

Zentek Ltd. announced that it expects to receive CAD 10.009022 million in funding

CEO & Director recently bought CA$149k worth of stock

Zen Graphene Solutions and Trebor Rx Announce Health Canada Approval for ZENGuardTM Mask

CEO & Director exercised options to buy CA$1.7m worth of stock.

President exercised options and sold CA$106k worth of stock

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

CEO & Director recently bought CA$146k worth of stock

ZEN Graphene Solutions Ltd. Develops Stable Diesel Fuel Additive

ZEN Graphene Solutions Ltd. announced that it has received CAD 4.337998 million in funding

ZEN Graphene Solutions Ltd. announced that it expects to receive CAD 2 million in funding

ZEN Graphene Solutions Ltd. Announces Successful Testing of its Graphene Compound Against Antimicrobial-Resistant Bacteria

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

ZEN Graphene Solutions and Trebor Rx Corp. Announce Successful Health Canada Testing Requirements of Surgical Masks

Zen Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound

ZEN Graphene Solutions Ltd. Announces Management Changes

New 90-day high: CA$3.75